oxazoles has been researched along with hoe 33342 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Alves, RJ; Badet, B; Del Puerto, HL; Dias, DF; Durand, P; Martins, AS; Martins-Filho, OA; Pinto, MC; Souza-Fagundes, EM; Teixeira-Carvalho, A | 1 |
Chen, R; Jing, W; Li, W; Luo, J; Peng, S; Su, X; Wang, Z; Ye, X; Zhou, M | 1 |
2 other study(ies) available for oxazoles and hoe 33342
Article | Year |
---|---|
Discovery of cytotoxic and pro-apoptotic compounds against leukemia cells: Tert-butyl-4-[(3-nitrophenoxy) methyl]-2,2-dimethyloxazolidine-3-carboxylate.
Topics: Antineoplastic Agents; Apoptosis; Benzimidazoles; Caspase 3; Cell Line, Tumor; Cell Survival; DNA Fragmentation; Drug Discovery; Flow Cytometry; Fluorescent Dyes; HL-60 Cells; Humans; Indicators and Reagents; Jurkat Cells; Leukemia; Microscopy, Fluorescence; Oxazoles; Phosphatidylserines; RNA, Messenger; Stereoisomerism | 2011 |
In vitro and ex vivo anti‑tumor effect and mechanism of Tucatinib in leukemia stem cells and ABCG2‑overexpressing leukemia cells.
Topics: Adenosine Triphosphatases; Adult; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Benzimidazoles; Cell Survival; Drug Resistance, Neoplasm; Female; Humans; Leukemia; Male; Mitoxantrone; Neoplasm Proteins; Neoplastic Stem Cells; Oxazoles; Pyridines; Quinazolines; Side-Population Cells; Tumor Cells, Cultured | 2021 |